Biomarin Pharmaceutical Inc
Statements
Balance Sheet
Biomarin Pharmaceutical Inc (BMRN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 11,723 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3,842 | 4,024 | 3,939 | 4,020 | 4,581 | 4,633 | 4,597 | 4,625 | 4,695 | 4,427 | 4,435 | 4,393 | 4,558 | 4,690 | 4,723 | 5,302 | 6,158 | 5,848 | 5,805 | 5,898 | 5,977 | 6,003 | 6,063 | 6,146 | 6,264 | 6,375 | 6,434 | 6,563 | 6,758 | 6,842 | 6,873 | 7,067 | 6,851 | 6,989 | 7,147 | 7,456 | 7,615 | 7,594 | 8,591 | 11,723 | |
| 1,667 | 1,422 | 1,353 | 1,459 | 2,050 | 2,207 | 2,241 | 2,280 | 2,408 | 2,056 | 1,917 | 1,807 | 1,859 | 1,942 | 2,116 | 2,648 | 2,739 | 2,342 | 2,289 | 2,358 | 2,312 | 2,274 | 2,394 | 2,518 | 2,683 | 2,751 | 2,842 | 2,950 | 2,955 | 2,956 | 2,985 | 3,260 | 3,057 | 3,232 | 3,468 | 3,805 | 3,855 | 3,953 | 4,605 | 3,972 | |
| 707 | 408 | 348 | 355 | 431 | 598 | 474 | 427 | 882 | 494 | 364 | 308 | 423 | 437 | 477 | 819 | 1,016 | 649 | 667 | 642 | 617 | 587 | 605 | 620 | 762 | 725 | 580 | 694 | 785 | 755 | 747 | 972 | 675 | 943 | 1,049 | 1,214 | 1,250 | 1,312 | 2,222 | 874 | |
| 1,035 | 790 | 678 | 728 | 1,257 | 1,396 | 1,383 | 1,363 | 1,443 | 1,084 | 895 | 731 | 721 | 754 | 858 | 1,380 | 1,506 | 1,065 | 1,087 | 1,123 | 1,079 | 1,014 | 1,056 | 1,110 | 1,274 | 1,292 | 1,152 | 1,171 | 1,126 | 1,074 | 1,047 | 1,224 | 930 | 1,138 | 1,272 | 1,432 | 1,478 | 1,561 | 2,222 | 874 | |
| 216 | 215 | 230 | 238 | 252 | 261 | 318 | 364 | 384 | 343 | 393 | 377 | 403 | 377 | 396 | 381 | 412 | 448 | 396 | 424 | 375 | 373 | 430 | 467 | 420 | 461 | 598 | 610 | 572 | 634 | 637 | 691 | 778 | 661 | 739 | 856 | 790 | 908 | 904 | 1,061 | |
| 347 | 355 | 384 | 430 | 457 | 476 | 468 | 473 | 508 | 531 | 535 | 579 | 609 | 680 | 706 | 744 | 701 | 699 | 714 | 711 | 749 | 777 | 786 | 802 | 839 | 894 | 919 | 976 | 1,032 | 1,107 | 1,138 | 1,184 | 1,179 | 1,233 | 1,275 | 1,340 | 1,382 | 1,299 | 1,273 | 1,783 | |
| 730 | 799 | 824 | 851 | 879 | 897 | 895 | 900 | 924 | 949 | 952 | 963 | 1,031 | 1,011 | 1,010 | 1,011 | 1,015 | 1,032 | 1,022 | 1,027 | 1,025 | 1,035 | 1,040 | 1,049 | 1,052 | 1,114 | 1,068 | 1,067 | 1,067 | – | – | – | – | – | – | – | – | – | – | – | |
| 197 | 197 | 197 | 197 | 197 | 197 | 197 | 197 | 197 | 197 | 197 | 197 | 197 | 197 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 196 | 656 | |
| 561 | 554 | 546 | 539 | 531 | 518 | 510 | 502 | 495 | 492 | 486 | 477 | 463 | 457 | 444 | 433 | 427 | 417 | 406 | 394 | 388 | 389 | 374 | 369 | 354 | 339 | 326 | 310 | 302 | 295 | 280 | 266 | 261 | 255 | 247 | 240 | 233 | 214 | 205 | 4,879 | |
| 1,196 | 1,257 | 1,170 | 1,224 | 1,767 | 1,824 | 1,790 | 1,740 | 1,780 | 1,459 | 1,499 | 1,432 | 1,484 | 1,568 | 1,483 | 2,065 | 2,104 | 1,742 | 1,643 | 1,657 | 1,711 | 1,733 | 1,671 | 1,641 | 1,696 | 1,772 | 1,775 | 1,780 | 1,861 | 1,890 | 1,799 | 1,781 | 1,438 | 1,331 | 1,354 | 1,429 | 1,558 | 1,507 | 2,379 | 5,402 | |
| 377 | 439 | 340 | 374 | 418 | 817 | 773 | 805 | 839 | 523 | 501 | 439 | 494 | 933 | 820 | 813 | 855 | 493 | 430 | 443 | 515 | 540 | 490 | 465 | 521 | 589 | 598 | 597 | 1,163 | 1,177 | 1,088 | 1,067 | 716 | 607 | 628 | 684 | 798 | 759 | 793 | 1,664 | |
| 22 | 22 | 22 | 676 | 17 | 361 | 365 | 370 | 374 | – | 9.2 | 10 | 10 | 373 | 376 | 381 | 385 | 12 | 11 | 11 | 9.7 | 10 | 11 | 11 | 9.2 | 10 | 9.3 | 8.3 | 503 | 503 | 503 | 506 | 8.1 | 7.6 | 6.3 | 7.7 | 7.6 | 8.7 | 9.3 | 674 | |
| 149 | 191 | 136 | 158 | 365 | 167 | 172 | 166 | 177 | 208 | 413 | 430 | 484 | 241 | 235 | 206 | 218 | 191 | 399 | 411 | 203 | 193 | 188 | 199 | 207 | 231 | 265 | 278 | 301 | 316 | 292 | 257 | 312 | 235 | 294 | 311 | 390 | 313 | 395 | 407 | |
| 653 | 661 | 668 | 676 | 1,166 | 814 | 818 | 822 | 826 | 830 | 835 | 839 | 844 | 486 | 487 | 1,073 | 1,074 | 1,075 | 1,076 | 1,077 | 1,078 | 1,079 | 1,080 | 1,081 | 1,082 | 1,083 | 1,084 | 1,085 | 593 | 593 | 594 | 594 | 595 | 595 | 596 | 596 | 597 | 597 | 1,430 | 3,528 | |
| 2,646 | 2,766 | 2,769 | 2,796 | 2,814 | 2,809 | 2,807 | 2,885 | 2,915 | 2,968 | 2,937 | 2,961 | 3,074 | 3,122 | 3,240 | 3,237 | 4,054 | 4,106 | 4,162 | 4,242 | 4,266 | 4,271 | 4,391 | 4,505 | 4,569 | 4,603 | 4,659 | 4,783 | 4,897 | 4,952 | 5,074 | 5,286 | 5,413 | 5,658 | 5,793 | 6,027 | 6,057 | 6,087 | 6,212 | 6,322 | |
| -1,573 | -1,521 | -1,537 | -1,574 | -1,586 | -1,638 | -1,661 | -1,678 | -1,690 | -1,694 | -1,753 | -1,791 | -1,736 | -1,721 | -1,639 | -1,669 | -884 | -862 | -844 | -831 | -868 | -926 | -805 | -777 | -789 | -789 | -738 | -682 | -642 | -622 | -533 | -426 | -320 | -195 | -9.0 | 232 | 201 | 154 | 260 | 304 | |
| 168 | 172 | 173 | 174 | 175 | 176 | 176 | 177 | 177 | 178 | 178 | 179 | 186 | 182 | 187 | 181 | 198 | 184 | 184 | 185 | 183 | 184 | 195 | 187 | 186 | 186 | 194 | 195 | 191 | 192 | 199 | 201 | 197 | 197 | 196 | 197 | 192 | 197 | 198 | 194 |
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.